Telix Pharmaceuticals Limited (ASX:TLX)
Australia
· Delayed Price · Currency is AUD 14.81
+0.25 (1.72%)
At close: Dec 5, 2025
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of 5.02 billion as of December 5, 2025. Its market cap has decreased by -34.15% in one year.
Market Cap
5.02B
Enterprise Value
5.34B
Revenue
1.01B
Ranking
n/a
PE Ratio
227.71
Stock Price
14.81
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from 152.03M to 5.02B, an increase of 3,199.52%. That is a compound annual growth rate of 54.31%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 88.01B |
| Pro Medicus | 26.57B |
| Cochlear | 17.94B |
| Sonic Healthcare | 11.43B |
| Ramsay Health Care | 8.59B |
| Ansell | 5.20B |
| Mesoblast | 3.23B |
| Neuren Pharmaceuticals | 2.42B |